About
Floris Hamel is a Senior Investment Manager and Team Lead for Life Science and MedTech at Brabantse Ontwikkelings Maatschappij (BOM), where he oversees early-stage investments in the life sciences sector. He has participated in over 35 equity investments up to €6 million across biotech, medical device, and agrifood companies, and previously provided strategic and financing guidance as a consultant at major life sciences consulting firms in the Benelux region. His expertise encompasses technical analysis of early- to mid-stage life science companies, strategic planning, and financial decision-making.
Experience
- Brabantse Ontwikkelings Maatschappij (BOM)Senior Investment Manager and Teamlead LifeScience & MedTechcurrent2026 — presentTilburg
- Brabantse Ontwikkelings Maatschappij (BOM)Senior Investment Manager Lifesciences & Medtech2023 — 2026Tilburg, Noord-Brabant, Nederland
- Brabantse Ontwikkelings Maatschappij (BOM)Investment Manager Life Sciences & Medtech2021 — 2023Netherlands
- NWO (Dutch Research Council)NWO Take-off Assessment Committee Chaircurrent2025 — presentUtrecht, Netherlands
- NWO (Dutch Research Council)NWO Take-off Assessment Committee Member2024 — 2025Utrecht, Netherlands
- Venture ChallengeVenture Challenge Assessment Committeecurrent2023 — present
- STENTiTShareholder Representativecurrent2022 — presentEindhoven, North Brabant, Netherlands
- STANTShareholder Representativecurrent2024 — presentOss, North Brabant, Netherlands
- UPyTherShareholder Representativecurrent2024 — presentEindhoven, North Brabant, Netherlands
- InProcess-LSPAdvisory Board Membercurrent2021 — presentOss, North Brabant, Netherlands
- CitryllShareholder Representativecurrent2024 — present
- CitryllBoard Observer2021 — 2024Oss, North Brabant, Netherlands
- Core Life AnalyticsShareholder Representative2021 — 2025's-Hertogenbosch, North Brabant, Netherlands
- ENPICOM BVShareholder Representative2021 — 2024's-Hertogenbosch, North Brabant, Netherlands
- ATRO Medical BVBoard Observer2021 — 2024Nijmegen, Gelderland, Netherlands
- Cristal TherapeuticsShareholder Representative2021 — 2024Maastricht, Limburg, Netherlands
- Glycostem TherapeuticsShareholder Representative2021 — 2024Oss, North Brabant, Netherlands
- Cytura TherapeuticsBoard Observer2021 — 2023Oss, North Brabant, Netherlands
- Synaffix BVBoard Observer2021 — 2023Oss, North Brabant, Netherlands
- Catalyze GroupStrategic Advisor & Investment Specialist2020 — 2021Amsterdam Area, Netherlands
Education
- Utrecht UniversityMaster’s Degree, Science and Business Management2014 — 2016
- Utrecht UniversityBachelor's Degree, Biology2010 — 2014
- Gymnasium BeekvlietVWO, Secundary School2002 — 2009
Skills & more
Molecular Biology10Life Sciences3Biotechnology4Scientific Writing1Antibodies4Cell Biology5Developmental Biology1BiochemistryMolecular & Cellular Biology2Data Analysis3Assay Development1Research2
Languages Dutch · English
From Floris's professional profile.
Colleagues at BOM
Bart Mul
Senior Investment Manager at BOM
Brigit van Dijk - van de Reijt
CEO at BOM
Daan van Lange
Associate at BOM
Ernst Coolen
Investment Director at BOM
Fabian Hendrix
Investment Manager at BOM
Ilse Massart
Senior Investment Manager at BOM
Ingrid Nieweg
Advisor at BOM
Jurgen van Eck
Senior Investment Manager at BOM
Network5
Bart Mul
Senior Investment Manager at BOM
Brigit van Dijk - van de Reijt
CEO at BOM
Daan van Lange
Associate at BOM
Ernst Coolen
Investment Director at BOM
Ilse Massart
Senior Investment Manager at BOM
Investors connected to Floris in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Floris Hamel work?
- Floris Hamel is Investor at BOM.
- What check size does Floris Hamel write?
- Floris Hamel typically writes checks of $100K – $5M.
Same school
Also attended Utrecht University85
Matthijs BlokhuisDirecteur at NoaberRoel DekkersInvestment manager at NoaberIrene KrijgsmanProgramma manager at NoaberMarlene van LooProgramma manager at NoaberRuben OsnabruggePartner & Chief Medical Officer at 415 CapitalDr. Benedikt BuchspiesPrincipal - Technology Research and Science at Planet A Ventures
+ 79 more
Also attended Gymnasium Beekvliet2
Shared employers
Also worked at Johnson & Johnson Ethicon, Inc.16
Catherine Pearce, DHSc, MBAAdvisor at CincyTechRuth SegallAssociate at Windham Capital PartnersAddie HarrisInvestor at 1955 CapitalSarah PappasSocial Media Strategist at Curate CapitalGeoff PardoGeneral Partner at Gilde HealthcareFred MollCo-Founder and Partner at Sonder Capital
+ 10 more
Also worked at Universiteit Utrecht19
Erik MeijerVenture Scout at Storm VenturesLaura LentzExecutive Assistant at Castle Island VenturesPim SwartAssociate Partner at Maven 11Tea EleziGeneral Partner at PeakRené KuijtenPartner, Head of EQT Life Sciences at EQT Life SciencesDiede BrunenPrincipal at BioGeneration Ventures
+ 13 more